Twenty Years Not Too Late: FDA Issues Guidance to Help PhRMA Talk Health Care Economic Information with Payers
Abstract
This article explains what manufacturer’s should know about the new draft guidelines, Drug and Device Manufacturer Communications with Payers, Formulary Committees, and Similar Entities – Questions and Answers.
Authors
Ruth Trzcienski